Kohno Y, Hiyama Y, Shimojo N, Niimi H, Nakajima H, Hosoya T
Clin Exp Immunol. 1986 Sep;65(3):534-41.
Using thyroid peroxidase (TPO), which was purified from the thyroid of patients with Graves' disease, we attempted to determine whether sera from patients with chronic thyroiditis contained antibodies to the enzyme. When the binding was tested by ELISA, sera from patients with chronic thyroiditis revealed high binding activities to TPO. When TPO was incubated with IgG from sera followed by treatment with protein A-Sepharose and centrifugation, the remaining TPO activities in the supernatant fraction were lower in most of the patients, as compared to normal controls. Moreover, IgG purified by DEAE-cellulose chromatography from sera in patients interfered with the TPO activities. Titres of anti-TPO antibodies correlated well with those of anti-microsome antibodies. These results indicate the presence of autoantibodies to TPO in sera of most patients with chronic thyroiditis and that TPO may be one component of microsome antigen complexes recognized by the autoantibodies. Studies on the inhibition of TPO by IgG isolated from sera of patients using guaiacol and iodide assays revealed that at least three epitopes of TPO molecule were recognized by autoantibodies and that the antigenic determinants on TPO molecule recognized by autoantibodies could be heterogeneous in patients.
我们使用从格雷夫斯病患者甲状腺中纯化得到的甲状腺过氧化物酶(TPO),试图确定慢性甲状腺炎患者血清中是否含有针对该酶的抗体。当通过酶联免疫吸附测定(ELISA)检测结合情况时,慢性甲状腺炎患者的血清显示出对TPO的高结合活性。当TPO与血清中的IgG一起孵育,随后用蛋白A-琼脂糖凝胶处理并离心时,与正常对照相比,大多数患者上清液部分中剩余的TPO活性较低。此外,通过DEAE-纤维素柱层析从患者血清中纯化的IgG会干扰TPO活性。抗TPO抗体的滴度与抗微粒体抗体的滴度高度相关。这些结果表明大多数慢性甲状腺炎患者血清中存在针对TPO的自身抗体,并且TPO可能是自身抗体识别的微粒体抗原复合物的一个组成部分。使用愈创木酚和碘化物测定法对从患者血清中分离的IgG对TPO的抑制作用进行的研究表明,自身抗体识别TPO分子的至少三个表位,并且在患者中自身抗体识别的TPO分子上的抗原决定簇可能是异质性的。